Literature DB >> 17016141

Acute alcoholic hepatitis.

Mauro Ceccanti1, Adolfo Attili, Giuseppe Balducci, Fabio Attilia, Stefano Giacomelli, Claudia Rotondo, Guido Francesco Sasso, Elias Xirouchakis, Maria Luisa Attilia.   

Abstract

Acute alcoholic hepatitis (AAH) is a frequent inflammatory liver disease with high short-term mortality rate. In this review, relationships between alcohol abuse and the epidemiology and the outcomes of AAH are discussed, as well as AAH pathogenesis. The role of endotoxins, tumor necrosis factor alpha, fibroblasts, and immune response to altered hepatocyte proteins is discussed. The need of a careful prognosis, supported by the use of Maddrey score, by the model for end-stage liver disease [Mayo end-stage liver disease (MELD)] score or by the Glasgow alcoholic hepatitis score, is outlined, as the use of the most effective drugs (glucocorticoids and anti-tumor necrosis factor alpha infliximab) is recommended only in severe AAH cases. The problems of liver transplant in severe AAH, and the need of a 6-month alcohol abstinence before transplant, are discussed, as well as the need of a careful psychologic assessment before the transplant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016141     DOI: 10.1097/01.mcg.0000225570.04773.5d

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  18 in total

1.  Definition, epidemiology and magnitude of alcoholic hepatitis.

Authors:  Sarpreet Basra; Bhupinderjit S Anand
Journal:  World J Hepatol       Date:  2011-05-27

2.  Symptoms and signs of acute alcoholic hepatitis.

Authors:  Gurjot Basra; Sarpreet Basra; Sreeram Parupudi
Journal:  World J Hepatol       Date:  2011-05-27

3.  Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression.

Authors:  Annayya R Aroor; Shivendra D Shukla
Journal:  World J Hepatol       Date:  2011-09-27

4.  Alcoholic liver disease-related mortality in the United States: 1980-2003.

Authors:  Helga Paula; Sumeet K Asrani; Nicholas C Boetticher; Rachel Pedersen; Vijay H Shah; W Ray Kim
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

5.  Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.

Authors:  Raul Lazaro; Raymond Wu; Sunyoung Lee; Nian-Ling Zhu; Chia-Lin Chen; Samuel W French; Jun Xu; Keigo Machida; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

6.  Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats.

Authors:  Annayya R Aroor; Daniel E Jackson; Shivendra D Shukla
Journal:  Alcohol Clin Exp Res       Date:  2011-07-25       Impact factor: 3.455

Review 7.  In vitro and in vivo models of acute alcohol exposure.

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.

Authors:  William O Osburn; Melinda S Yates; Patrick D Dolan; Sining Chen; Karen T Liby; Michael B Sporn; Keiko Taguchi; Masayuki Yamamoto; Thomas W Kensler
Journal:  Toxicol Sci       Date:  2008-04-15       Impact factor: 4.849

Review 9.  Pentoxifylline for alcoholic hepatitis.

Authors:  Kate Whitfield; Andrea Rambaldi; Jørn Wetterslev; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 10.  Alcoholic hepatitis: current challenges and future directions.

Authors:  Ashwani K Singal; Patrick S Kamath; Gregory J Gores; Vijay H Shah
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.